sefulness umbilical cord blood transfusion in neonates
Phase 1
- Conditions
- Health Condition 1: P619- Perinatal hematological disorder,unspecified
- Registration Number
- CTRI/2020/04/024701
- Lead Sponsor
- SS Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Neonates >34 week gestation admitted in NICU requiring Blood Transfusion & whose parents gave legal consent for the procedure.
Exclusion Criteria
1.Patient who were not willing for the procedure.
2. Neonates who have earlier h/o blood transfusion.
3. Syndromic Neonates and those with Congenital Anomaly.
4. Neonates with hemolytic disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method mortality of subjects <br/ ><br>appearance of side effectsTimepoint: Appearance of side effects : at the time of tranfusion <br/ ><br>1 hour after transfusion <br/ ><br>2 hour after transfusion <br/ ><br>Mortality of subjects: at the time of discharge
- Secondary Outcome Measures
Name Time Method usefulness of umblical cord blood transfusion in neonatal careTimepoint: from admission in nicu to discharge.